Market Cap (In INR)
10.66 Billion
Revenue (In INR)
6.14 Billion
Net Income (In INR)
509.56 Million
Avg. Volume
1.07 Million
- Currency
- INR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 198.0-369.7
- PE
- -
- EPS
- -
- Beta Value
- 0.578
- ISIN
- INE082A01010
- CUSIP
- Y4821P114
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Mr. Surendra Shrikrishna Somani B.Com.
- Employee Count
- -
- Website
- https://www.kopran.com
- Ipo Date
- 2002-07-01
- Details
- Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.
More Stocks
-
CLAZF
-
EMITFElbit Imaging Ltd.
EMITF
-
GROV
-
3020
-
CHEWA
-
600021
-
VENUSPIPESVenus Pipes and Tubes Limited
VENUSPIPES
-
KASHYAPKashyap Tele-Medicines Limited
KASHYAP